Suppr超能文献

饮食模式、肠道微生物群重塑与心血管代谢疾病

Dietary Patterns, Gut Microbiota Remodeling, and Cardiometabolic Disease.

作者信息

Guiducci Letizia, Nicolini Giuseppina, Forini Francesca

机构信息

CNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, Italy.

出版信息

Metabolites. 2023 Jun 17;13(6):760. doi: 10.3390/metabo13060760.

Abstract

The cardiovascular and metabolic disorders, collectively known as cardiometabolic disease (CMD), are high morbidity and mortality pathologies associated with lower quality of life and increasing health-care costs. The influence of the gut microbiota (GM) in dictating the interpersonal variability in CMD susceptibility, progression and treatment response is beginning to be deciphered, as is the mutualistic relation established between the GM and diet. In particular, dietary factors emerge as pivotal determinants shaping the architecture and function of resident microorganisms in the human gut. In turn, intestinal microbes influence the absorption, metabolism, and storage of ingested nutrients, with potentially profound effects on host physiology. Herein, we present an updated overview on major effects of dietary components on the GM, highlighting the beneficial and detrimental consequences of diet-microbiota crosstalk in the setting of CMD. We also discuss the promises and challenges of integrating microbiome data in dietary planning aimed at restraining CMD onset and progression with a more personalized nutritional approach.

摘要

心血管和代谢紊乱统称为心脏代谢疾病(CMD),是发病率和死亡率较高的病症,与生活质量下降和医疗成本增加相关。肠道微生物群(GM)在决定CMD易感性、进展和治疗反应的人际差异方面的影响正开始被解读,GM与饮食之间建立的共生关系也是如此。特别是,饮食因素已成为塑造人类肠道中常驻微生物的结构和功能的关键决定因素。反过来,肠道微生物会影响摄入营养物质的吸收、代谢和储存,对宿主生理产生潜在的深远影响。在此,我们提供了关于饮食成分对GM的主要影响的最新概述,强调了在CMD背景下饮食与微生物群相互作用的有益和有害后果。我们还讨论了在饮食规划中整合微生物组数据的前景和挑战,旨在通过更个性化的营养方法抑制CMD的发生和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73da/10301429/802da6dee180/metabolites-13-00760-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验